rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1997-10-29
|
pubmed:abstractText |
Lymphomas of the paranasal sinuses may have poorer prognoses compared with other extranodal lymphomas of the head and neck, and are not well defined as a particular clinicopathologic entity. The outcome of combined-modality therapy and central nervous system (CNS) prophylaxis has not been fully determined.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1081-4442
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
303-11
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9327155-Adolescent,
pubmed-meshheading:9327155-Adult,
pubmed-meshheading:9327155-Aged,
pubmed-meshheading:9327155-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9327155-Cyclophosphamide,
pubmed-meshheading:9327155-Doxorubicin,
pubmed-meshheading:9327155-Female,
pubmed-meshheading:9327155-Humans,
pubmed-meshheading:9327155-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:9327155-Lymphoma, Non-Hodgkin,
pubmed-meshheading:9327155-Male,
pubmed-meshheading:9327155-Middle Aged,
pubmed-meshheading:9327155-Neoplasm Staging,
pubmed-meshheading:9327155-Paranasal Sinus Neoplasms,
pubmed-meshheading:9327155-Prednisone,
pubmed-meshheading:9327155-Retrospective Studies,
pubmed-meshheading:9327155-Survival Analysis,
pubmed-meshheading:9327155-Treatment Outcome,
pubmed-meshheading:9327155-Vincristine
|
pubmed:articleTitle |
Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
|
pubmed:affiliation |
Department of Medicine, Stanford University, California, USA.
|
pubmed:publicationType |
Journal Article
|